Loading...
XJSEGRT
Market cap2.39bUSD
Dec 20, Last price  
1,293.00ZAR
1D
0.31%
1Q
-7.38%
Jan 2017
-50.06%
Name

Growthpoint Properties Ltd

Chart & Performance

D1W1MN
XJSE:GRT chart
P/E
3,450.96
P/S
304.09
EPS
0.37
Div Yield, %
0.00%
Shrs. gr., 5y
2.88%
Rev. gr., 5y
4.50%
Revenues
14.40b
+4.81%
1,181,714,0001,380,172,0002,362,000,0002,920,000,0003,430,000,0004,206,000,0004,640,000,0005,290,000,0005,782,000,0006,605,000,0007,870,000,00010,219,000,00010,755,000,00010,926,000,00011,554,000,00012,361,000,00013,126,000,00013,048,000,00013,740,000,00014,401,000,000
Net income
1.27b
-46.14%
482,000603,0001,000,000-98,000,000-69,000,000106,000,000-235,000,000-921,000,000-1,006,000,0005,579,000,0006,955,000,0005,159,000,0007,524,000,0006,663,000,0006,321,000,000-6,865,000,000-497,000,0007,937,000,0002,356,000,0001,269,000,000
CFO
5.74b
-20.98%
16,450,0002,744,00099,000,000384,000,00093,000,000204,000,000-235,000,000-773,000,000-166,000,000-34,000,000-1,357,000,000652,000,000-603,000,0006,762,000,0006,458,000,0005,557,000,0004,876,000,0005,798,000,0007,258,000,0005,735,000,000
Dividend
Oct 16, 202458.3 ZAR/sh
Earnings
Mar 11, 2025

Profile

Growthpoint is the largest South African primary JSE-listed REIT with a quality portfolio of 440 directly owned properties in South Africa (RSA) valued at R73.4bn, including four hospitals and one medical chambers valued at R2.6bn owned by Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint has a 61.8% shareholding in GHPH. We have a 62.2% interest in ASX-listed Growthpoint Properties Australia Limited (GOZ), which owns 58 properties in Australia valued at R51.8bn and a 52.1% interest in LSE-listed Capital & Regional Plc (C&R), which owns seven properties in the United Kingdom valued at R14.8bn.
URL
https://growthpoint.co.za/
IPO date
Jul 01, 1992
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
14,401,000
4.81%
13,740,000
5.30%
13,048,000
-0.59%
Cost of revenue
4,985,000
4,295,000
3,936,000
Unusual Expense (Income)
NOPBT
9,416,000
9,445,000
9,112,000
NOPBT Margin
65.38%
68.74%
69.83%
Operating Taxes
(988,000)
240,000
1,293,000
Tax Rate
2.54%
14.19%
NOPAT
10,404,000
9,205,000
7,819,000
Net income
1,269,000
-46.14%
2,356,000
-70.32%
7,937,000
-1,696.98%
Dividends
(5,227,000)
(4,458,000)
(4,163,000)
Dividend yield
Proceeds from repurchase of equity
407,000
17,448,000
13,380,000
BB yield
Debt
Debt current
7,055,000
5,935,000
9,434,000
Long-term debt
67,806,000
72,382,000
66,509,000
Deferred revenue
97,000
63,695,000
54,240,000
Other long-term liabilities
635,000
(62,245,000)
(53,423,000)
Net debt
53,942,000
55,347,000
56,107,000
Cash flow
Cash from operating activities
5,735,000
7,258,000
5,798,000
CAPEX
(60,000)
(48,000)
(36,000)
Cash from investing activities
(4,149,000)
(2,324,000)
(3,597,000)
Cash from financing activities
(3,136,000)
682,000
2,945,000
FCF
10,543,000
22,952,000
(198,000)
Balance
Cash
1,798,000
3,362,000
2,841,000
Long term investments
19,121,000
19,608,000
16,995,000
Excess cash
20,198,950
22,283,000
19,183,600
Stockholders' equity
85,068,000
91,941,000
90,501,000
Invested Capital
138,258,050
146,546,000
145,787,400
ROIC
7.31%
6.30%
5.67%
ROCE
5.79%
5.42%
5.35%
EV
Common stock shares outstanding
3,409,428
3,420,915
3,419,088
Price
Market cap
EV
EBITDA
9,540,000
9,515,000
9,294,000
EV/EBITDA
Interest
5,308,000
4,356,000
3,190,000
Interest/NOPBT
56.37%
46.12%
35.01%